UK markets open in 3 hours 43 minutes
NIKKEI 225
38,299.71 +25.66 (+0.07%) HANG SENG
18,153.20 +390.17 (+2.20%) CRUDE OIL
79.38 +0.38 (+0.48%) GOLD FUTURES
2,327.80 +16.80 (+0.73%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,784.04 -2,037.85 (-4.26%)
Kezar Life Sciences, Inc. (KZR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 60.06M |
| Enterprise value | -122.38M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.55 |
| Price/book (mrq) | 0.32 |
| Enterprise value/revenue | -17.48 |
| Enterprise value/EBITDA | 1.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.46 |
| 52-week change 3 | -67.69% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 3.1300 |
| 52-week low 3 | 0.6700 |
| 50-day moving average 3 | 0.8852 |
| 200-day moving average 3 | 1.0845 |
Share statistics
| Avg vol (3-month) 3 | 794.23k |
| Avg vol (10-day) 3 | 591.35k |
| Shares outstanding 5 | 72.8M |
| Implied shares outstanding 6 | 72.8M |
| Float 8 | 52.48M |
| % held by insiders 1 | 14.81% |
| % held by institutions 1 | 67.93% |
| Shares short (15 Apr 2024) 4 | 3.82M |
| Short ratio (15 Apr 2024) 4 | 4.26 |
| Short % of float (15 Apr 2024) 4 | 5.43% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.25% |
| Shares short (prior month 15 Mar 2024) 4 | 3.38M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,503.39% |
Management effectiveness
| Return on assets (ttm) | -25.26% |
| Return on equity (ttm) | -44.54% |
Income statement
| Revenue (ttm) | 7M |
| Revenue per share (ttm) | 0.10 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -104.17M |
| Net income avi to common (ttm) | -101.87M |
| Diluted EPS (ttm) | -1.4000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 201.37M |
| Total cash per share (mrq) | 2.77 |
| Total debt (mrq) | 18.93M |
| Total debt/equity (mrq) | 10.09% |
| Current ratio (mrq) | 11.66 |
| Book value per share (mrq) | 2.58 |
Cash flow statement
| Operating cash flow (ttm) | -81.64M |
| Levered free cash flow (ttm) | -39.23M |
© 2024 Yahoo. All rights reserved.